Elyse G. Seltzer
Corporate Officer/Principal presso Yale University
Posizioni attive di Elyse G. Seltzer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Yale University | Corporate Officer/Principal | - | - |
Storia della carriera di Elyse G. Seltzer
Precedenti posizioni note di Elyse G. Seltzer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| UROGEN PHARMA LTD. | Chief Tech/Sci/R&D Officer | 12/12/2017 | 01/04/2020 |
| Corporate Officer/Principal | 01/04/2020 | 01/05/2023 | |
| NABRIVA THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 23/06/2017 | 30/09/2017 |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Chief Tech/Sci/R&D Officer | 04/05/2015 | 01/09/2017 |
| GSK PLC | Corporate Officer/Principal | 01/09/2009 | 01/04/2015 |
| TENGION, INC. | Chief Tech/Sci/R&D Officer | 01/11/2006 | 01/08/2009 |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Corporate Officer/Principal | - | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Corporate Officer/Principal | - | - |
Formazione di Elyse G. Seltzer
| University of Pennsylvania | Undergraduate Degree |
| New York University School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 9 |
| Regno Unito | 2 |
| Austria | 2 |
Posizioni
| Corporate Officer/Principal | 6 |
| Chief Tech/Sci/R&D Officer | 4 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 9 |
| Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| TENGION, INC. | Health Technology |
| GSK PLC | Health Technology |
| UROGEN PHARMA LTD. | Health Technology |
| NABRIVA THERAPEUTICS PLC | Health Technology |
| Aziende private | 3 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Health Technology |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Health Technology |
- Borsa valori
- Insiders
- Elyse G. Seltzer
- Esperienza
